Hazem Abou-Youssef

Hazem Abou-Youssef

Auto-generated profile, based on publicly available information

Hazem Abou-Youssef

Clinical/Chemical Pathology, Cairo University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Pediatrics
Verified
Journal Article
Open access
PDF file
IIIman Iskander
Iman Iskander
RGRasha Gamaleldin
Rasha Gamaleldin
SHSalma El Houchi
Salma El Houchi
ASAmira El Shenawy
Amira El Shenawy
ISIman Seoud
Iman Seoud
RWRichard P. Wennberg
Richard P. Wennberg
BACKGROUND AND OBJECTIVE: Bilirubin/albumin ratio (B/A) may provide a better estimate of free bilirubin than total serum bilirubin (TSB), thus improving identification of newborns at risk for bilirubin encephalopathy. The objective of the study was to identify thresholds and compare specificities of TSB and B/A in detecting patients with acute and posttreatment auditory and neurologic impairment. METHODS: A total of 193 term/near-term infants, admitted for severe jaundice to Cairo University Children’s Hospital, were evaluated for neurologic status and auditory impairment (automated auditory brainstem response), both at admission and posttreatment by investigators blinded to laboratory results. The relationships of TSB and B/A to advancing stages of neurotoxicity were compared by using receiver operating characteristic curves. RESULTS: TSB and B/A ranged from 17 to 61 mg/dL and 5.4 to 21.0 mg/g, respectively; 58 (30%) of 193 subjects developed acute bilirubin encephalopathy, leading to kernicterus in 35 infants (13 lethal). Auditory impairment was identified in 86 (49%) of 173 infants at admission and in 22 of 128 at follow-up. In the absence of clinical risk factors, no residual neurologic or hearing impairment occurred unless TSB exceeded 31 mg/dl. However, transient auditory impairment occurred at lower TSB and B/A (22.9 mg/dL and 5.7 mg/g, respectively). Intervention values of TSB and B/A set at high sensitivity to detect different stages of neurotoxicity had nearly the same specificity. CONCLUSIONS: Both TSB and B/A are strong predictors of neurotoxicity, but B/A does not improve prediction over TSB alone. Threshold values detecting all affected patients (100% sensitivity) increase with advancing severity of neurotoxicity.

1 August 2010 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
MEMortada Hassan El-Shabrawi
Mortada Hassan El-Shabrawi
NMNabil A. Mohsen
Nabil A. Mohsen
MSMai M. Sherif
Mai M. Sherif
HEHanaa M. El-Karaksy
Hanaa M. El-Karaksy
HAHazem Abou-Yosef
Hazem Abou-Yosef
AEAhmed El-Hennawy
Ahmed El-Hennawy
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatic fibrosis. Liver biopsy, because of its limitations and risks, might be considered an imperfect gold standard for assessing the severity of chronic liver diseases. In this study, we aimed to prospectively validate FibroTest (FT) and ActiTest (AT) as noninvasive serum biochemical markers for assessment of the degree of hepatic fibrosis and necroinflammatory activity respectively, in pediatric patients with chronic HCV infection and compare them to liver biopsy. Fifty patients, aged 2 to 18 years, with chronic HCV infection were prospectively enrolled. Two assessments were carried out, within 24-h duration, one of a liver biopsy specimen and the other FT and AT measured in serum sample. A highly significant linear trend and correlation were found between FT-related fibrosis and fibrosis stage by METAVIR scoring on histopathological examination. A highly significant correlation was also found between AT and necroinflammatory histological activity using METAVIR as well. The FT area under the receiver operating characteristic curve (AUROC) is 0.97, SE=0.02 which can diagnose patients with mild stage of fibrosis, thus discriminating them from those with no (or minimal) fibrosis. The AT can successfully discriminate between patients with moderate activity and those with mild activity with AUROC=0.93, SE=0.06. FT and AT are potential noninvasive methods for assessment of hepatic fibrosis and necroinflammatory activity in pediatric patients with chronic HCV infection in comparison with liver biopsy.

25 January 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SHSalma Z. El Houchi
Salma Z. El Houchi
IIIman Iskander
Iman Iskander
RGRasha Gamaleldin
Rasha Gamaleldin
ASAmira El Shenawy
Amira El Shenawy
ISIman Seoud
Iman Seoud
RWRichard P. Wennberg
Richard P. Wennberg

10 July 2013 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
SESherif M. M. Ekladious
Sherif M. M. Ekladious
Marianne Samir Makboul IssacMarianne Samir Makboul Issac
Marianne Samir Makboul Issac
SSSahar Abd El-Atty Sharaf
Sahar Abd El-Atty Sharaf
HAHazem S. Abou-Youssef
Hazem S. Abou-Youssef

20 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HAHazem S Abou-Youssef
Hazem S Abou-Youssef
MKManal M Kamal
Manal M Kamal
DMDina A Mehaney
Dina A Mehaney
The incidence of Down syndrome (DS) in Egypt varies between 1∶555 and 1∶770 and its screening by triple test is becoming increasingly popular nowadays. Results, however, seem inaccurate due to the lack of Egyptian-specific information needed for risk calculation and a clear policy for programme implementation. Our study aimed at calculation and validation of the triple marker medians used in screening Egyptian females as well as to recommend programme conventions to unify screening in this country. The study was conducted on 668 Egyptian women, in weeks 15–20 of pregnancy as proven by sonar. Chorionic gonadotropin (CG), α-fetoprotein (AFP) and unconjugated oestriol (uE3) were measured on Siemens Immulite analyzer. Medians of the three parameters were calculated, regressed against gestational age (GA) and weighted by the number of participants/week. Equations were derived to adjust each parameter to the maternal weight and were centered on the median Egyptian weight. Prisca software was fed with the above data, multiples-of-median (MoM) and DS risks were calculated and the screening performance was evaluated at a mid-trimester risk cutoff of 1∶270. Log-linear [AFP/uE3 = 10(A+B*GA)] and exponential equations [CG = A*e (B*GA)] were derived and the regressed medians were found to follow similar patterns to other Asian and Western medians. Oestriol was always lowest (even halved) while CG and AFP were intermediate. A linear reciprocal model best fitted weight distribution among Egyptians and successfully adjusted each parameter to a weight of 78.2 kg. Epidemiological monitoring of these recommendations revealed satisfactory performance in terms of 6.7% initial positive rate and 1.00 grand MoM. Adoption of the above recommendations is hoped to pave the way to a successful DS screening programme tailored to Egyptian peculiarities.

21 December 2017 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FEFatma Elmougy
Fatma Elmougy
SSSahar Sharaf
Sahar Sharaf
MHMona Hafez
Mona Hafez
AKAhmed Khattab
Ahmed Khattab
HAHazem Abou‐Yousef
Hazem Abou‐Yousef
HSHend Soliman
Hend Soliman